HMB represented Quantitative Insights, developer of QuantX, the first-ever FDA-cleared computer-aided breast cancer diagnosis system in radiology, in its sale to Qlarity Imaging, a portfolio company of Paragon Biosciences. Quantitative Insights was founded at the University of Chicago around technology developed at the University and with the support of the University’s Polsky Center for Entrepreneurship and Innovation. Paragon is a Chicago-based life science innovator that invests in, builds and advises bioscience companies. Qlarity Imaging will further develop QuantX and plans to expand the diagnostic applications of its AI technology to additional image modalities and medical conditions, with the goal of improving patient care while lowering costs for hospitals and payers. Read more here.